Know Cancer

or
forgot password


Phase 3
18 Years
75 Years
Open (Enrolling)
Both
Non-small Cell Lung Cancer

Thank you

Trial Information


Inclusion Criteria:



- Early stage NSCLC and no metastasis of hilum of lung and mediastinum lymph nodes
(short diameter ≤ 1 cm) on computed tomography (CT) scan;

- No medical contraindications to lung resection

- Age ≤ 75 years old and ≥18 years old;

- Sign the informed consent form.

Exclusion Criteria:

- Evidence of invasion into neighboring organs;

- Extensive pleura adhesion;

- Central lesion;

- Not suitable for single-lung ventilation;

- Had history of thoracotomy and radiation for thoracic region ;

- Pregnancy or lactation female patients;

- Cannot sign the informed consent form because of psychological, family and society
factors;

- Had history of other malignant tumors within 5 years except for non-melanoma
cutaneous cancer, uterine cervix cancer in situ and curative early-stage carcinoma of
prostate;

- Participants can not accept operation for other uncontrolled factors.

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment

Outcome Measure:

Disease-free survival and overall survival

Outcome Time Frame:

5 years

Safety Issue:

Yes

Principal Investigator

Hao Long, professor

Investigator Role:

Principal Investigator

Investigator Affiliation:

Sun Yat-sen University

Authority:

China: Ethics Committee

Study ID:

2007039

NCT ID:

NCT01102517

Start Date:

January 2010

Completion Date:

January 2018

Related Keywords:

  • Non-Small Cell Lung Cancer
  • NSCLC
  • Clinical
  • Early-stage
  • Carcinoma, Non-Small-Cell Lung
  • Lung Neoplasms

Name

Location